Abstract

transit time (MTT). The findings were compared with pathological/cytological results or long time of follow up. Results: To eliminate patient and exam-related factors, such as interactions of the contrast agent with anticoagulants, stenoses in vessels, and changes in heart rate and heart time volume, etc. CH-EUS was performed in 26 patients with a solid lesion in pancreas (16 carcinomas, 9 chronic pancreatitis, and 1 solid pseudopapillary tumor) with certain pathological/cytological results or follow up over 2 years and 5 patients with normal pancreas. Accordingly, for subsequent analyses, only the differences between the lesion and the normal pancreatic tissue of each patient were used. In CH-EUS, the malignant tumor was relatively hypointense compared to the surrounding pancreatic tissue, resulting in consistently positive values in difference of IMAX( IMAX IMAXnormal-IMAXtumor). The TTP was, on average, 36 seconds longer in PDACs than in the normal tissue, while in CP the TTP was similar or only a few seconds longer than in the normal tissue. And the RT in cancerous lesions was significantly longer than in healthy pancreas and non-cancerous lesions. With the use of quantification software, as in our study, this visual impression can thus be detected and measured with a sensitivity that is unachievable with subjective visual impressions alone. Conclusions: Contrast quantification software supplements a subjective visual assessment with objective criteria to facilitate the differential diagnosis of focal lesions in pancreatic cancer and non-cancerous lesions of pancreas, and needs further investigation. Values of the Characteristic Parameters of the Time-Intensity Curve Measured in the Normal Pancreas, and in suspicious lesions of pancreatic cancer, chronic pancreatitis, and SPPT of the pancreas

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call